Thursday Jun 13
Market Report, "The Medicines Company (MDCO) - Financial and...
The Medicines Company is a pharmaceutical company providing medical solutions for improving health conditions in critical care patients.
The Medicines Compan Now Covered by Piper Jaffray
"We believe MDCO is on the cusp of significant diversification of its hospital product portfolio that in our view will bolster already strong cash generation over the next few years.
The Medicines Company to Participate in Goldman Sachs 34th Annual Global Healthcare Conference
About The Medicines Company The Medicines Company provides medical solutions to improve health outcomes for patients in acute and intensive care hospitals worldwide.
The Medicines Compan Coverage Initiated by Analysts at Piper Jaffray
The firm set an "overweight" rating on the stock. The analysts wrote, "We believe MDCO is on the cusp of significant diversification of its hospital product portfolio that in our view will bolster already strong cash generation over the next few years.
The Medicines Company to Acquire ProFibrix with $10M Upfront Payment
The Medicines Company and ProFibrix B.V. today announced an agreement for The Medicines Company to purchase all of the outstanding capital stock of ProFibrix B.V. subject to The Medicines Company's satisfactory review of the pending Phase 3 clinical trial results of ProFibrix's lead biologic, Fibrocaps .Fibrocaps is a dry powder topical formulation ... (more)
The Medicines Company to Participate in Jefferies 2013 Global Healthcare Conference
The Medicines Company is scheduled to present at the Jefferies 2013 Global Healthcare Conference on Tuesday, June 4th at 8:30 AM Eastern Time.